tiprankstipranks
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market
KZIA
Kazia Therapeutics
RESEARCH TOOLSreports

Kazia Therapeutics (KZIA) Stock News & Sentiment

328 Followers
Kazia Therapeutics Licenses SETDB1 Epigenetic Platform to Bolster Oncology Pipeline
Premium
Company Announcements
Kazia Therapeutics Licenses SETDB1 Epigenetic Platform to Bolster Oncology Pipeline
21h ago
6K
KZIA
Kazia Therapeutics Announces Board Changes and AGM Outcomes as It Highlights Oncology Pipeline
Premium
Company Announcements
Kazia Therapeutics Announces Board Changes and AGM Outcomes as It Highlights Oncology Pipeline
14d ago
6K
KZIA
Kazia Therapeutics Taps Leerink for New ATM Facility as Cash Bolstered by Late-2025 PIPE
Premium
Company Announcements
Kazia Therapeutics Taps Leerink for New ATM Facility as Cash Bolstered by Late-2025 PIPE
15d ago
6K
KZIA
Kazia Therapeutics Posts Wider Half-Year Loss but Bolsters Cash, Pipeline and Nasdaq Compliance
Premium
Company Announcements
Kazia Therapeutics Posts Wider Half-Year Loss but Bolsters Cash, Pipeline and Nasdaq Compliance
26d ago
6K
KZIA
Kazia Therapeutics Posts Early Efficacy Signals for Paxalisib Combo in Metastatic Triple-Negative Breast Cancer
Premium
Company Announcements
Kazia Therapeutics Posts Early Efficacy Signals for Paxalisib Combo in Metastatic Triple-Negative Breast Cancer
3M ago
6K
KZIA
Kazia Therapeutics Retains Nasdaq Listing After Regaining Compliance
Premium
Company Announcements
Kazia Therapeutics Retains Nasdaq Listing After Regaining Compliance
4M ago
6K
KZIA
Kazia Therapeutics Unveils Promising Paxalisib Data at Breast Cancer Symposium
Premium
Company Announcements
Kazia Therapeutics Unveils Promising Paxalisib Data at Breast Cancer Symposium
4M ago
6K
KZIA
More KZIA News >

KZIA News on the Web

Kazia Therapeutics Licenses SETDB1 Epigenetic Platform to Bolster Oncology Pipeline
TipRanks News
Neutral
Kazia Therapeutics in-licenses drug development platform from QIMR Berghofer
TipRanks News
Bullish
Kazia Therapeutics Announces Board Changes and AGM Outcomes as It Highlights Oncology Pipeline
TipRanks News
Neutral
Kazia Therapeutics Taps Leerink for New ATM Facility as Cash Bolstered by Late-2025 PIPE
TipRanks News
Neutral
Kazia Therapeutics Ltd Annual Shareholders Meeting Transcript
GuruFocus News
Neutral
Kazia Therapeutics Posts Wider Half-Year Loss but Bolsters Cash, Pipeline and Nasdaq Compliance
TipRanks News
Bearish
Kazia Therapeutics’ NDL2 shows anti-tumor efficacy in preclinical data
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Korro Bio (KRRO), Kazia Therapeutics (KZIA) and AbbVie (ABBV)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
KZIA
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KZIA’s Media Buzz Sentiment?
2 articles about KZIA were published this week. In an average week, 1.5 articles are published.
    What is KZIA’s weekly average amount of articles?
    In an average week, 1.5 articles about KZIA are published.
      What is KZIA’s News Sentiment?
      100% of articles about KZIA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        STAAStaar Surgical
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week